Ignite Creation Date:
2024-05-06 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05022342
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2021-08-20
Brief Title:
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis